| < i> In vitro</i> and< i> in vivo</i> antioxidant properties of chlorogenic acid and caffeic acid Y Sato, S Itagaki, T Kurokawa, J Ogura, M Kobayashi, T Hirano, ... International Journal of Pharmaceutics 403 (1), 136-138, 2011 | 1140 | 2011 |
| Involvement of Cholesterol Membrane Transporter Niemann-Pick C1-Like 1 in the Intestinal Absorption of Lutein Y Sato, R Suzuki, M Kobayashi, S Itagaki, T Hirano, T Noda, S Mizuno, ... Journal of Pharmacy & Pharmaceutical Sciences 15 (2), 256-264, 2012 | 66 | 2012 |
| Pharmacokinetic properties of lutein emulsion after oral administration to rats and effect of food intake on plasma concentration of lutein Y Sato, M Kobayashi, S Itagaki, T Hirano, T Noda, S Mizuno, M Sugawara, ... Biopharmaceutics & Drug Disposition 32 (3), 151-158, 2011 | 40 | 2011 |
| Enhancement of lymphatic transport of lutein by oral administration of a solid dispersion and a self-microemulsifying drug delivery system Y Sato, T Joumura, S Nashimoto, S Yokoyama, Y Takekuma, H Yoshida, ... European Journal of Pharmaceutics and Biopharmaceutics 127, 171-176, 2018 | 38 | 2018 |
| Protective effect of soy isoflavone genistein on ischemia-reperfusion in the rat small intestine Y Sato, S Itagaki, S Oikawa, J Ogura, M Kobayashi, T Hirano, ... Biological and Pharmaceutical Bulletin 34 (9), 1448-1454, 2011 | 34 | 2011 |
| Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case–control study K Ikuta, S Nakagawa, K Momo, A Yonezawa, K Itohara, Y Sato, S Imai, ... BMJ open 11 (2), e041543, 2021 | 29 | 2021 |
| Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study S Kadomura, Y Takekuma, Y Sato, M Sumi, K Kawamoto, T Itoh, ... Journal of pharmaceutical health care and sciences 5, 1-8, 2019 | 28 | 2019 |
| Emulsification using highly hydrophilic surfactants improves the absorption of orally administered coenzyme q10. Y Sato, H Mutoh, M Suzuki, Y Takekuma, K Iseki, M Sugawara Biological & Pharmaceutical Bulletin 36 (12), 2012-2017, 2013 | 27 | 2013 |
| Protective effect of lutein after ischemia-reperfusion in the small intestine Y Sato, M Kobayashi, S Itagaki, T Hirano, T Noda, S Mizuno, M Sugawara, ... Food Chemistry 127 (3), 893-898, 2011 | 27 | 2011 |
| A Risk Prediction Flowchart of Vancomycin-Induced Acute Kidney Injury to Use When Starting Vancomycin Administration: A Multicenter Retrospective Study T Miyai, S Imai, H Kashiwagi, Y Sato, S Kadomura, K Yoshida, ... Antibiotics 9 (12), 920, 2020 | 21 | 2020 |
| Enhancement of intestinal absorption of coenzyme Q10 using emulsions containing oleyl polyethylene acetic acids Y Sato, S Yokoyama, Y Yamaki, Y Nishimura, M Miyashita, S Maruyama, ... European Journal of Pharmaceutical Sciences 142, 105144, 2020 | 19 | 2020 |
| Intracellular Uptake Mechanism of Lutein in Retinal Pigment Epithelial Cells Y Sato, Y Kondo, M Sumi, Y Takekuma, M Sugawara Journal of Pharmacy & Pharmaceutical Sciences 16 (3), 494-501, 2013 | 18 | 2013 |
| Using Japanese big data to investigate novel factors and their high‐risk combinations that affect vancomycin‐induced nephrotoxicity S Imai, S Kadomura, T Miyai, H Kashiwagi, Y Sato, M Sugawara, ... British Journal of Clinical Pharmacology, 2022 | 17 | 2022 |
| Transport via Niemann-Pick C1 Like 1 contributes to the intestinal absorption of ubiquinone S Nashimoto, Y Takekawa, Y Takekuma, M Sugawara, Y Sato Drug Metabolism and Pharmacokinetics, 2020 | 17 | 2020 |
| An Approach to Improve Intestinal Absorption of Poorly Absorbed Water-Insoluble Components via Niemann–Pick C1-Like 1 Y Takekawa, Y Sato, Y Yamaki, M Imai, K Noto, M Sumi, Y Takekuma, ... Biological and Pharmaceutical Bulletin 39 (3), 301-307, 2016 | 17 | 2016 |
| Transfer of orally administered hyaluronan to the lymph Y Sato, T Joumura, Y Takekuma, M Sugawara European Journal of Pharmaceutics and Biopharmaceutics 154, 210-213, 2020 | 14 | 2020 |
| Use of Japanese big data from electronic medical records to investigate risk factors and identify their high-risk combinations for linezolid-induced thrombocytopenia Y Inoue, Y Takekuma, T Miyai, H Kashiwagi, Y Sato, M Sugawara, S Imai European Journal of Clinical Pharmacology 79 (3), 415-425, 2023 | 13 | 2023 |
| Characterization of the disposition of lutein after iv administration to rats S Itagaki, W Ogura, Y Sato, T Noda, T Hirano, S Mizuno, K Iseki Biological and Pharmaceutical Bulletin 29 (10), 2123-2125, 2006 | 11 | 2006 |
| Machine Learning-Based Model for Estimating Vancomycin Maintenance Dose to Target the Area under the Concentration Curve of 400–600 mg· h/L in Japanese Patients T Miyai, S Imai, E Yoshimura, H Kashiwagi, Y Sato, H Ueno, Y Takekuma, ... Biological and Pharmaceutical Bulletin 45 (9), 1332-1339, 2022 | 10 | 2022 |
| Implementation Status of Liver Function Tests for Monitoring Benzbromarone-Induced Hepatotoxicity: An Epidemiological Survey Using the Japanese Claims Database S Imai, Y Nasuhara, K Momo, H Oki, H Kashiwagi, Y Sato, T Miyai, ... Biological and Pharmaceutical Bulletin 44 (10), 1499-1505, 2021 | 10 | 2021 |
